US$ 27.23
flow trial semaglutide Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT ๐จ#FLOW: The most anticipated trial
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Leshan RL, Greenwald-Yarnell M, Patterson CM, Gonzalez IE, Myers MG

They are not fertility drugs, and they should not be used during pregnancy unless a qualified clinician specifically advises otherwise

Many people who didnt lose enough weight on semaglutide do better on tirzepatide

2024 Feb;6(2):290-303
doi: 10.1007/s00125-010-2028-x

Thats why paying attention to nutrition and training becomes even more important
